| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/07/2001 | EP0730735A4 Glucose calibrator and control material for test strips |
| 02/07/2001 | CN1283235A Method for producing complex DNA methylation fingerprints |
| 02/07/2001 | CN1283234A Method for suppressing multiple drug resistant in cancer cells |
| 02/07/2001 | CN1283232A Use of novel disintegrin metalloprotease, mutants, fragments and the like |
| 02/07/2001 | CN1283230A Desaturated enzyme |
| 02/07/2001 | CN1283227A Expression cloning in filamentous fungi |
| 02/07/2001 | CN1283224A Hyaluronan synthase gene and uses thereof |
| 02/07/2001 | CN1283121A HIV-ITAT or derwatives thereof for prophylatic and therapeutic vacceination |
| 02/07/2001 | CN1283108A I (chlamydia) protein, gene sequence and uses thereof |
| 02/07/2001 | CN1283082A Carbohydrate oxidase and use thereof in baking |
| 02/07/2001 | CN1282793A Reagent for testing angiotonin converzyme and its application and test method |
| 02/07/2001 | CN1061686C Method for detecting polymerase chain reaction product and reagent box |
| 02/06/2001 | US6184435 Transgenic mouse expressing APP770-V717F |
| 02/06/2001 | US6184389 Feature a plurality of functional groups attached to backbone and phosphoramidate sites |
| 02/06/2001 | US6184379 Rhodamine derivatives and the use thereof |
| 02/06/2001 | US6184371 Lactoferrin receptor genes of Moraxella |
| 02/06/2001 | US6184364 Dehydrating uridine to form 2,2'-anhydrouridine, converting to unprotected 2'-azido-2'-deoxyuridine, iodinating to form 5-iodo-2'-azido, 2'-deoxyuridine, then reducing to 5-iodo, 2'-amino-2'-deoxyuridine; selex ligands |
| 02/06/2001 | US6184357 Antibody which binds a preferential polypeptide; for the diagnosis, prevention and treatment of prostate cancer and hyperplasia |
| 02/06/2001 | US6184353 Method for modulating processes mediated by farnesoid activated receptors |
| 02/06/2001 | US6184256 Methods and compositions for use in modulating expression of matrix metalloproteinase genes |
| 02/06/2001 | US6184212 Antisense modulation of human mdm2 expression |
| 02/06/2001 | US6184202 Modulating apoptosis of a cell by administering an agent comprising a bh1 or bh2 domain capable of promoting or inhibiting formation of a complex of bcl-2:blc-2; bcl-xl:bcl-xl; bax:bax; and/or bcl-xl:bax |
| 02/06/2001 | US6184032 Identification of genes encoding cell surface antigens using CREF-Trans 6 cells |
| 02/06/2001 | US6184030 Biologically-active polymers |
| 02/06/2001 | US6184029 Apparatus for the detection and analysis of particles or microorganisms in sample |
| 02/06/2001 | US6184027 Recovering, isolating and purifying eubacteria or fungus from sample; incubate sample with deactivated protein which is bound to solid phase matrix, wash, isolate and recover purified microorganisms |
| 02/06/2001 | US6184025 Nucleotide sequences for the detection and diagnosis of viral diseases |
| 02/06/2001 | US6184016 Polypeptides having prenylcysteine carboxyl methyltransferase activity or inhibiting activity |
| 02/06/2001 | US6184011 Method of releasing solid matrix affinity adsorbed particulates |
| 02/06/2001 | US6183999 Restricting sensitivity of polymerase chain reaction so that only parvovirus concentrations greater than specific threshold point are detected; processing blood for transfusions |
| 02/06/2001 | US6183998 Modified thermostable dna polymerase which has been deactivated by crosslinking with an aldehyde under aqueous conditions; enzyme can be activated by heating; for use in polymerase chain reactions |
| 02/06/2001 | US6183995 Methods of measuring gene expression using wax-embedded tissue specimens |
| 02/06/2001 | US6183986 OspA DNA and lyme disease vaccine |
| 02/06/2001 | US6183981 Diagnostic assay for late-onset Alzheimer's disease |
| 02/06/2001 | US6183978 Luciferase assay, compositions and kits for use in connection therewith |
| 02/06/2001 | US6183977 Determining hepatic status of a liver transplant recipient by measuring PI glutathione S-transferase |
| 02/06/2001 | US6183974 Transfecting specific cells which express urokinase plasminogen activator and have suppressed gs signaling of enzyme with expression vector coding for g protein coupled receptor, contacting with compound, measuring enzyme activity |
| 02/06/2001 | US6183973 Vibrio vulnificus molecular probes, antibodies, and proteins |
| 02/06/2001 | US6183970 Polynucleotide probe chip and polynucleotide detection method |
| 02/06/2001 | US6183968 Mixture of polynucleotide probes of defined nucleotide sequences; microarray for use in hybridization screening |
| 02/06/2001 | US6183967 Nucleic acid ligand inhibitors to DNA polymerases |
| 02/06/2001 | US6183963 Oligonucleotides for use as polymerase chain reaction primers and hybridization probes; for detection of polymorphisms in n-acetyltransferase 2 and cytochrome p450 enzymes; determines cancer susceptibility and drug sensitivity |
| 02/06/2001 | US6183962 Nucleotide sequence of cardiovascular system associated protein kinase; antisense agents; recombinant expression vectors; host cells for culture production; diagnosis and treatment of cardiovascular disorders; probes; primers; kits |
| 02/06/2001 | US6183960 Kit for selectively amplifying nucleic acid sequences; includes open circle probes, a rolling circle replication primer, and a secondary dna strand displacement primer; for accurate, simple, and sensitive diagnosis |
| 02/06/2001 | US6183958 Probes for variance detection |
| 02/06/2001 | US6183957 Method for isolating a polynucleotide of interest from the genome of a mycobacterium using a BAC-based DNA library application to the detection of mycobacteria |
| 02/06/2001 | US6183956 High throughput in vitro screening assays for transcription modulators |
| 02/06/2001 | US6183955 Methods for determining the coat color genotype of a pig |
| 02/06/2001 | US6183954 Method for evaluating the metastatic tendency of tumors |
| 02/06/2001 | US6183952 Contacting test sample with polynucleotide of defined nucleotide sequence or complementary sequence and detecting presence of bu101 polynucleotide; diagnosing, staging, monitoring, prognosticating cancer, tumors, and metastases |
| 02/06/2001 | US6183950 Method and apparatus for detecting viruses using primary and secondary biomarkers |
| 02/06/2001 | US6183772 Doped liposomes comprise: a) a plurality of polymerized diynes; b) one or more ligands having an affinity for said analyte; and c) a dopant having no affinity for said analyte. |
| 02/06/2001 | US6183754 Anticytomegalovirus monoclonal antibodies and processes for the in vitro diagnosis of infections by human cytomegaloviruses and a protein-kinase inducible by cytomegaloviruses and recognizable by aforesaid monoclonal antibodies |
| 02/06/2001 | US6183752 Gene expression of exogenous epitope of cytomegalo virus; genetic engineering |
| 02/06/2001 | US6183751 Unique associated Kaposi's Sarcoma virus sequences and uses thereof |
| 02/06/2001 | US6183740 Recombinant bacterial phytases and uses thereof |
| 02/06/2001 | CA2315306A1 Process for the preparation in pure form of the protease activating blood clotting factor vii, its proenzyme or a mixture of both proteins by means of ion-exchange chromatography |
| 02/06/2001 | CA2181190C Mesoscale sample preparation device and systems for determination and processing of analytes |
| 02/06/2001 | CA2130947C Dry elements, test devices, test kits and methods for chemiluminescent detection of analytes using peroxidase-labeled reagents |
| 02/06/2001 | CA2028789C Kinetic assay for endotoxin using limulus amebocyte lysate and chromogenic substrate |
| 02/06/2001 | CA2005589C Self-sustained, sequence replication system |
| 02/05/2001 | CA2311201A1 Ests and encoded human proteins |
| 02/04/2001 | CA2314878A1 High throughput hplc method for determining log p values |
| 02/01/2001 | WO2001007918A1 Catalytic anti-factor viii allo-antibodies |
| 02/01/2001 | WO2001007917A1 Determining antibodies to ny-eso-1 in cancer patients |
| 02/01/2001 | WO2001007916A1 Method for diagnosing diseases and pathological states |
| 02/01/2001 | WO2001007915A2 Layered device with capture regions for cellular analysis |
| 02/01/2001 | WO2001007910A1 Method and apparatus for detecting enzymatic activity using molecules that change electrophoretic mobility |
| 02/01/2001 | WO2001007908A2 Improvements in and relating to forensic investigations |
| 02/01/2001 | WO2001007898A1 Micro-array information display method |
| 02/01/2001 | WO2001007665A2 Sequence determination of nucleic acids using electronic detection |
| 02/01/2001 | WO2001007664A2 Genome analysis |
| 02/01/2001 | WO2001007663A1 Methods and compositions for diagnosing palmoplantar keratodermas and dysplasias and other periodontal diseases |
| 02/01/2001 | WO2001007662A1 Drug target isogenes: polymorphisms in the prostaglandin-endoperoxide synthase 2 gene |
| 02/01/2001 | WO2001007661A2 Polynucleotide amplification method |
| 02/01/2001 | WO2001007660A1 Methods for detection of ataxia telangiectasia mutations |
| 02/01/2001 | WO2001007659A2 Methods for identifying inhibitors of signaling molecules |
| 02/01/2001 | WO2001007658A1 Abc transport polynucleotides, polypeptides, and antibodies |
| 02/01/2001 | WO2001007655A1 Antisense modulation of shp-2 expression |
| 02/01/2001 | WO2001007654A1 Method for identifying compounds which modulate circadian rhythm |
| 02/01/2001 | WO2001007653A1 Spatially-encoded analyte detection |
| 02/01/2001 | WO2001007652A2 Detection of human hepatitis b virus surface antigen mutants by specific amplification and its application on gene chip |
| 02/01/2001 | WO2001007651A2 Transposon mediated differential hybridisation |
| 02/01/2001 | WO2001007650A2 Improvements in and relating to forensic investigations |
| 02/01/2001 | WO2001007649A2 Method for detecting microorganisms |
| 02/01/2001 | WO2001007648A1 Method for the species-specific detection of organisms |
| 02/01/2001 | WO2001007647A2 Method for relative quantization of methylation of cytosin-type bases in dna samples |
| 02/01/2001 | WO2001007646A2 Method for quantization of the antiviral effect of antiviral active principles |
| 02/01/2001 | WO2001007645A2 Method for marking solid, liquid and gaseous substances |
| 02/01/2001 | WO2001007644A2 Genotyping of the paraoxonase 1 gene for prognosing, diagnosing, and treating a disease |
| 02/01/2001 | WO2001007643A1 Method for detecting pathogenic microorganism and antimicrobial agent, method for evaluating the drug effect of antimicrobial agent, and antimicrobial agents |
| 02/01/2001 | WO2001007642A1 Computer-assisted formulation of culture media |
| 02/01/2001 | WO2001007641A2 Method for expressing a library of nucleic acid sequence variants and selecting desired traits |
| 02/01/2001 | WO2001007640A2 Method for detecting single nucleotide polymorphisms |
| 02/01/2001 | WO2001007638A2 Homogeneous fluorescence method for assaying structural modifications of biomolecules |
| 02/01/2001 | WO2001007630A1 Novel cytochrome p450 monooxygenases and their use for oxidizing organic compounds |
| 02/01/2001 | WO2001007628A2 Human synthetases |
| 02/01/2001 | WO2001007624A2 Dna sequences which are suited for specifically detecting pseudomonas putida kt2440 |
| 02/01/2001 | WO2001007623A1 Epoxide hydrolases from streptomyces |
| 02/01/2001 | WO2001007616A1 Polynucleotide encoding autoantigens associated with endometriosis |